Ordinary Index Rebalancing in the Solactive Future Pharmaceutical Europe Index | September 2020

In the ordinary rebalance the following composition will be implemented effective open 07.09.2020:

ARGENX SE
ASTRAZENECA PLC
BAYER AG
GLAXOSMITHKLINE PLC
GRIFOLS SA CLASS A
HIKMA PHARMACEUTICALS PLC
IPSEN SA
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
UCB SA
VIFOR PHARMA AG